IgC Bio Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

IgC Bio General Information

Description

Operator of a biotechnology company intended to develop computational epitope-specific antibodies. The company develops antibodies using structural design technologies to engineer stable monoclonal antibodies, enabling physicians to use patented algorithms for antibody design and development.

Contact Information

Website
igc.bio
Formerly Known As
ABDesign
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 50 Congress Street
  • Suite 1040
  • Boston, MA 02109
  • United States
+1 (617)
Primary Industry
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 50 Congress Street
  • Suite 1040
  • Boston, MA 02109
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IgC Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-May-2019 Completed Startup
2. Early Stage VC 24-Jul-2018 Completed Startup
1. Early Stage VC 14-Oct-2016 $2.5M $2.5M Completed Startup
To view IgC Bio’s complete valuation and funding history, request access »

IgC Bio Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

IgC Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200126640-A1 Computational affinity maturation of antibody libraries using sequence enumeration Inactive 17-Oct-2018
US-20190367614-A1 Anti-pd-1 scfvs Inactive 08-Jan-2018
US-20200207844-A1 Anti-vegf antibody Inactive 12-Sep-2017
WO-2019055399-A1 Anti-vegf antibody Inactive 12-Sep-2017
US-20200291366-A1 Pross optimized enzymes Inactive 12-Sep-2017 C12N9/1096
To view IgC Bio’s complete patent history, request access »

IgC Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biological Engineering Ventures Venture Capital Minority
To view IgC Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

IgC Bio FAQs

  • When was IgC Bio founded?

    IgC Bio was founded in 2014.

  • Where is IgC Bio headquartered?

    IgC Bio is headquartered in Boston, MA.

  • What industry is IgC Bio in?

    IgC Bio’s primary industry is Biotechnology.

  • Is IgC Bio a private or public company?

    IgC Bio is a Private company.

  • What is IgC Bio’s current revenue?

    The current revenue for IgC Bio is .

  • How much funding has IgC Bio raised over time?

    IgC Bio has raised $4.7M.

  • Who are IgC Bio’s investors?

    Biological Engineering Ventures has invested in IgC Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process